Status post coronary artery bypass grafting x 3 ([**2141-2-28**]).
Take back, reexploration for left internal mammary artery kink/torsion ([**2141-3-2**]).
The patient was treated per their protocol with Lovenox and Plavix, given her allergy to aspirin.
She was continued on her other cardiac medications including nitrates, beta blockade and ACE inhibitor.
Plavix 75 mg q.d.
Magnesium oxide 400 mg b.i.d.
Digoxin 0.125 mg q.d.
Colace 100 mg b.i.d.
Multivitamin q.d.
Vitamin C 250 mg q.d.
Tums 500 mg t.i.d.
Lisinopril 40 mg q.d.
Iron sulfate 325 mg q.d.
Macrobid 100 mg p.o.
Coumadin 2 mg q.d.
Aldactone 45 mg q.d.
Fosamax 70 mg q. week.
Lopressor 75 mg b.i.d.
Isordil 40 mg t.i.d.
Lasix 20 mg Monday, Wednesday, and Friday.
Percocet p.r.n.
Vital signs: Temperature 97.8, heart rate 82, blood pressure 140/80, respiratory rate 18, saturating 98% on two liters nasal cannula.
It was decided to proceed with coronary artery bypass grafting.
On [**2141-2-27**] the patient was taken to the operating room for coronary artery bypass grafting x 3 with left internal mammary artery to the left anterior descending coronary artery, left radial to the obtuse marginal and right radial to the RPL.
The patient tolerated the procedure well.
The patient was maintained on multiple drips including insulin, Milrinone, Neo-Synephrine, nitroglycerin and propofol.
The ultimate etiology for renal failure was thought to be ATN, multifactorial, with prerenal component due to congestive heart failure, contrast nephropathy, ischemic ATN from intraoperative hypoperfusion.
The patient did respond to amiodarone and electrical cardioversion x 3.
There was a recommendation for a soft solid diet with thin liquids.
The patient also was thought to benefit from supplemental nutrition.
During her period on the floor the patient's main issues were simply diuresis as well as anticoagulation for atrial fibrillation.
pain medications and having a therapeutic INR.
Lopressor 12.5 mg b.i.d.
Lasix 20 mg b.i.d.
Percocet 5/325 [**1-19**] q.
Colace 100 mg b.i.d.
Plavix 75 mg q.d.
Imdur 60 mg q.d.
Nystatin 5 mL q.i.d.
Coumadin 1 mg q.d., titrate as necessary for INR of between 2 and 3.
The patient should follow up with cardiology within 1-2 weeks and address the need for continued diuresis as well as adjustment of cardiac medications at that time.
Her anticipated Coumadin dosage will probably be 1-2 mg q.d.
The patient will also require aggressive physical therapy with transfer and balance training, eventual gait training, and ambulation strengthening.
The patient should also adhere to a cardiac and gluten-free diet supplemented by Boost or equivalent t.i.d.
